Novel injectable sodium alginate hydrogel developed for improved endometrial repair with human umbilical cord mesenchymal stem cells

In: Drug Delivery and Translational Research · 2025 · vol. 15(12) , pp. 4638–4653 · doi:10.1007/s13346-025-01846-4 · PMID:40195258 · W4409271529
article OA: closed CC0
AI-generated summary by claude@2026-06+body, 2026-06-09

An injectable RGD-modified sodium alginate hydrogel with calcium gluconate crosslinking enhanced human umbilical cord mesenchymal stem cell delivery for improved endometrial repair in a mouse model.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

The study developed a novel injectable sodium alginate hydrogel for endometrial regeneration by encapsulating human umbilical cord mesenchymal stem cells (UCMSCs). The authors used calcium gluconate crosslinking to improve hydrogel homogeneity and injectability versus calcium chloride, and modified the scaffold with RGD to enhance UCMSC adhesion, proliferation, and differentiation in vitro. In a mouse model of endometrial injury, intrauterine transplantation of RGD-modified UCMSC-loaded hydrogel improved endometrial thickness, reduced fibrosis, increased angiogenesis, and raised pregnancy rates compared with untreated controls and UCMSCs alone. The paper does not report data availability and indicates raw/processed data cannot be shared due to technical or time limitations. This paper is centrally about endometriosis—specifically endometrial repair using an injectable UCMSC hydrogel aimed at treating endometrial damage that is relevant to endometriosis-associated tissue dysfunction.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

This study presents a novel injectable sodium alginate hydrogel designed to enhanc stem cell therapy for endometrial regeneration. Using calcium gluconate as a crosslinking agent, we achieved improved homogeneity and injectability compared to traditional calcium chloride crosslinking. RGD modification further enhanced cell adhesion, proliferation, and differentiation in vitro, creating a bioactive scaffold for umbilical cord mesenchymal stem cells (UCMSCs) delivery. In a mouse model of endometrial injury, intrauterine transplantation of RGD-modified hydrogel encapsulating UCMSCs significantly improved endometrial thickness, reduced fibrosis, enhanced angiogenesis, and increased pregnancy rates compared to both untreated controls and UCMSCs alone. These results suggest that this injectable hydrogel system combined with stem cells holds significant promise for future applications in treating endometrial damage and improving reproductive outcomes in women.
Full text 11,185 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

This study presents a novel injectable sodium alginate hydrogel designed to enhanc stem cell therapy for endometrial regeneration. Using calcium gluconate as a crosslinking agent, we achieved improved homogeneity and injectability compared to traditional calcium chloride crosslinking. RGD modification further enhanced cell adhesion, proliferation, and differentiation in vitro, creating a bioactive scaffold for umbilical cord mesenchymal stem cells (UCMSCs) delivery. In a mouse model of endometrial injury, intrauterine transplantation of RGD-modified hydrogel encapsulating UCMSCs significantly improved endometrial thickness, reduced fibrosis, enhanced angiogenesis, and increased pregnancy rates compared to both untreated controls and UCMSCs alone. These results suggest that this injectable hydrogel system combined with stem cells holds significant promise for future applications in treating endometrial damage and improving reproductive outcomes in women. Graphical Abstract Similar content being viewed by others Data availability The raw/processed data required to reproduce these findings cannot be shared at this time due to technical or time limitations. Change history 18 April 2025 Author equal contribution statement was added.

References

Zhu X, et al. Stem cells and endometrial regeneration: from basic research to clinical trial. Curr Stem Cell Res Ther. 2019;14(4):293–304. Robinson JK, Colimon LMS, Isaacson KB. Postoperative adhesiolysis therapy for intrauterine adhesions (Asherman’s syndrome). Fertil Steril. 2008;90(2):409–14. Hooker AB, et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update. 2014;20(2):262–78. Zhu HY, et al. Human menstrual blood-derived stem cells promote the repair of impaired endometrial stromal cells by activating the p38 MAPK and AKT signaling pathways. Reprod Biol. 2018;18(3):274–81. Chen L, et al. Transplantation of menstrual blood-derived mesenchymal stem cells (MbMSCs) promotes the regeneration of mechanical injuried endometrium. Am J Transl res. 2020;12(9):4941–54. Santamaria X, et al. Autologous cell therapy with CD133+bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod. 2016;31(5):1087–96. Çil N, et al. Adipose derived mesenchymal stem cell treatment in experimental asherman syndrome induced rats. Mol Biol Rep. 2020;47(6):4541–52. Park M, et al. Perivascular stem cell-derived cyclophilin a improves uterine environment with Asherman’s syndrome via HIF1α-dependent angiogenesis. Mol Ther. 2020;28(8):1818–32. Zheng JH, et al. Quantification of the CM-Dil-labeled human umbilical cord mesenchymal stem cells migrated to the dual injured uterus in SD rat. Stem Cell Res Ther. 2020;11(1). Xu L, et al. Umbilical cord-derived mesenchymal stem cells on scaffolds facilitate collagen degradation via upregulation of MMP-9 in rat uterine scars. Stem Cell Res Ther. 2017;8. Yang H, et al. Vitamin C plus hydrogel facilitates bone marrow stromal cell-mediated endometrium regeneration in rats. Stem Cell Res Ther. 2017;8. Cao Y, et al. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther. 2018;9. Naahidi S, et al. Biocompatibility of hydrogel-based scaffolds for tissue engineering applications. Biotechnol Adv. 2017;35(5):530–44. Tang J-N, et al. Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future. Stem Cells Transl Med. 2018;7(4):354–9. Marycz K. et al. Nanocrystalline hydroxyapatite loaded with resveratrol in colloidal suspension improves viability, metabolic activity and mitochondrial potential in Human Adipose-Derived Mesenchymal Stromal Stem Cells (hASCs). Polymers. 2019;11(1). Ma Y, et al. 3D Spatiotemporal mechanical microenvironment: a hydrogel-based platform for guiding stem cell fate. Adv Mater. 2018; 30(49). Bai X, et al. Dual crosslinked chondroitin sulfate injectable hydrogel formed via continuous Diels-Alder (DA) click chemistry for bone repair. Carbohyd Polym. 2017;166:123–30. Qu Y, et al. α-Tocopherol liposome loaded chitosan hydrogel to suppress oxidative stress injury in cardiomyocytes. Int J Biol Macromol. 2019;125:1192–202. Urie R, et al. Inorganic Nanomaterials for Soft Tissue Repair and Regeneration. In: Annual Review of Biomedical Engineering, Vol 20, M.L. Yamush, Editor. 2018. p. 353–374. Chien KH, et al. Promoting induced pluripotent stem cell-driven biomineralization and periodontal regeneration in rats with maxillary-molar defects using injectable BMP-6 hydrogel. Sci Rep. 2018;8. Zhang SS, et al. Using 17β-estradiol heparin-poloxamer thermosensitive hydrogel to enhance the endometrial regeneration and functional recovery of intrauterine adhesions in a rat model. FASEB J. 2020;34(1):446–57. Zhang S-S, et al. Three-dimensional structure micelles of heparinpoloxamer improve the therapeutic effect of 17β-estradiol on endometrial regeneration for intrauterine adhesions in a rat model. Int J Nanomed. 2017;12:5643–57. Liu X, et al. An in situ photocrosslinkable platelet rich plasma - Complexed hydrogel glue with growth factor controlled release ability to promote cartilage defect repair. Acta Biomater. 2017;62:179–87. Li H, et al. A Hydrogel Bridge Incorporating Immobilized Growth Factors and Neural Stem/Progenitor Cells to Treat Spinal Cord Injury. Adv Healthcare Mater. 2016;5(7):802–12. Charnockjones DS, et al. Identification and localization of alternately spliced messenger-rnas for vascular endothelial growth-factor in human uterus and estrogen regulation in endometrial carcinoma cell-lines. Biol Reprod. 1993;48(5):1120–8. Girling JE, Rogers PAW. Recent advances in endometrial angiogenesis research. Angiogenesis. 2005;8(2):89–99. Ferenczy A, Bertrand G, Gelfand MM. Proliferation kinetics of human-endometrium during the normal menstrual-cycle. Am J Obstet Gynecol. 1979;133(8):859–67. Gluzman-Poltorak Z, et al. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 (vol 275, pg 18040, 2000). J Biol Chem. 2000;275(38):29922–29922. Fan X, et al. VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. FASEB J. 2008;22(10):3571–80. Paulin D, et al. Vimentin: Regulation and pathogenesis. Biochimie. 2022;197:96–112. Ferriani RA, et al. Immunohistochemical localization of acidic and basic fibroblast growth-factors in normal human endometrium and endometriosis and the detection of their messenger-rna by polymerase chain-reaction. Hum Reprod. 1993;8(1):11–6. Merviel P, et al. The role of integrins in human embryo implantation. Fetal Diagn Ther. 2001;16(6):364–71. Kim S-M, Kim J-S. A Review of Mechanisms of Implantation. Dev Reprod. 2017;21(4):351–9. Cheng JG, et al. Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proc Natl Acad Sci USA. 2001;98(15):8680–5. Charnockjones DS, et al. Leukemia inhibitory factor messenger-RNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains messenger-RNA for the receptor at this time. J Reprod Fertil. 1994;101(2):421–6. Suman P, Malhotra SS, Gupta SK. LIF-STAT signaling and trophoblast biology. Jak-Stat. 2013;2(4):e25155–e25155. Arici A, et al. Leukaemia inhibitory factor expression in human follicular fluid and ovarian cells. Hum Reprod. 1997;12(6):1233–9. Li X, et al. Recent developments in bio-scaffold materials as delivery strategies for therapeutics for endometrium regeneration. Materials Today Bio. 2021;11. Wu M, et al. HOXA10 Expressing UCMSCs Transplantation Improved Endometrial Receptivity on Endometrial Injury. Curr Stem Cell Res Ther. 2023;18(7):1001–12. Wang J, et al. Application of Bioactive Hydrogels for Functional Treatment of Intrauterine Adhesion. Front Bioeng Biotechnol. 2021;9. Zhang E, et al. Fouling-resistant zwitterionic polymers for complete prevention of postoperative adhesion. Proc Natl Acad Sci USA. 2020;117(50):32046–55. Raus RA, Nawawi WMFW, Nasaruddin RR. Alginate and alginate composites for biomedical applications. Asian J Pharm Sci. 2021;16(3):280–306. Janmey PA, Miller RT. Mechanisms of mechanical signaling in development and disease. J Cell Sci. 2011;124(1):9–18. Peng K, et al. Derivation of haploid trophoblast stem cells via conversion in vitro. iScience. 2019;11:508–18. Zhang W, et al. Rif1 and Hmgn3 regulate the conversion of murine trophoblast stem cells. Cell Rep. 2022;38(13):110570. Lansdown AB, Payne MJ. An evaluation of the local reaction and biodegradation of calcium sodium alginate (Kaltostat) following subcutaneous implantation in the rat. J R Coll Surg Edinb. 1994;39(5):284–8. Lan S-F, Safiejko-Mroczka B, Starly B. Long-term cultivation of HepG2 liver cells encapsulated in alginate hydrogels: A study of cell viability, morphology and drug metabolism. Toxicol In Vitro. 2010;24(4):1314–23. Patil SS, Nune KC, Misra RDK. Alginate/poly(amidoamine) injectable hybrid hydrogel for cell delivery. J Biomater Appl. 2018;33(2):295–314. Lv H, et al. Hydrogel, a novel therapeutic and delivery strategy, in the treatment of intrauterine adhesions. J Mater Chem B. 2021;9(33):6536–52.

Acknowledgements

We thank Dr. Yihan Wan (School of Life Sciences, West Lake University) for her kind suggestions. Funding This work was supported by the National Natural Science Foundation of China (32170800 and 31871490) and the National Key Research and Development Program of China (2018YFA0800100). It is also supported by the Fundamental Research Funds for the Central Universities (22120240435). Author information Authors and Affiliations Contributions J. X. and YY. L., designed the research; YF. L., WM. Y. and RX. Wang., conducted the experiments; HQ. D assisted with the experiments; LH. S. and YY. L. provided technical and resource support; J. X. and YF. L. wrote the manuscript. All authors read and approved the final manuscript. Corresponding authors Ethics declarations Conflict of interest None declared. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Author equal contribution statement was added. Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Li, Y., Yin, W., Dong, H. et al. Novel injectable sodium alginate hydrogel developed for improved endometrial repair with human umbilical cord mesenchymal stem cells. Drug Deliv. and Transl. Res. 15, 4638–4653 (2025). https://doi.org/10.1007/s13346-025-01846-4 Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s13346-025-01846-4

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (52)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK